Cathie Wood Invests $32 Million in CoreWeave Stock and Acquires Bitcoin Dip Through ARKB, While Ark Invest Also Buys Shares in George Soros-Backed Firm
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 25 2025
0mins
Should l Buy KDK?
Source: Benzinga
Ark Invest's Recent Trades: Cathie Wood's Ark Invest made significant acquisitions, including shares in CoreWeave Inc., ARK 21Shares Bitcoin ETF, Bullish, and Kodiak AI Inc., reflecting a strategic focus on emerging technologies and digital assets.
CoreWeave Acquisition: Ark's flagship funds purchased 437,345 shares of CoreWeave for approximately $32.2 million, capitalizing on the company's recent stock surge driven by Nvidia's strong earnings and increased interest in AI technologies.
Bitcoin ETF Investment: Ark funds acquired 36,638 shares of ARK 21Shares Bitcoin ETF, valued at around $1.08 million, amidst a turbulent cryptocurrency market where Bitcoin prices have significantly declined.
Investments in Bullish and Kodiak AI: Ark Invest bought shares in Bullish after its strong earnings report and invested in Kodiak AI to leverage the growing autonomous vehicle market, which is projected to be worth $4 trillion.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy KDK?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on KDK
Wall Street analysts forecast KDK stock price to rise
5 Analyst Rating
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 8.350
Low
13.00
Averages
14.38
High
17.00
Current: 8.350
Low
13.00
Averages
14.38
High
17.00
About KDK
Kodiak AI Inc is a provider of artificial intelligence (AI)-powered autonomous vehicle (AV) technology that is designed to help tackle some of the toughest driving jobs. The Company's driverless solution can help address the critical problem of safely transporting goods in the face of unprecedented supply chain challenges. It has developed the Kodiak Driver, a virtual driver that combines advanced AI-powered software with modular and vehicle-agnostic hardware designed to help address its customers' needs. The Kodiak Driver is designed to operate across a variety of environments. It is a single, common technology platform that is designed to operate across multiple vehicle types and in a variety of driving domains. The Kodiak Driver is designed to see the road, analyze its surroundings, use limited pre-existing information and incorporate real-time perception. The Company serves customers in the long-haul trucking, industrial trucking and defense industries.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Cathie Wood's Investment Outlook for 2026
- Joby Aviation Investment: Despite Joby Aviation's stock plummeting 17% after announcing a $1.2 billion stock and convertible note offering, it still achieved a 33% return over the past year, indicating market confidence in the long-term potential of electric vertical takeoff and landing aircraft, with Wood's increased stake signaling her bullish outlook.
- Kodiak AI Challenges: Kodiak AI's market cap has dropped from $2.5 billion to $1.6 billion, and while its technology in autonomous trucking is promising, the current operation of only 10 commercial vehicles suggests insufficient market acceptance, making Wood's investment a bet on future growth potential.
- CRISPR Therapeutics Outlook: CRISPR set multiple milestones for 2026, with its Casgevy treatment generating over $100 million in revenue last year; despite its stock being down 76% from its all-time high five years ago, plans to expand treatment usage may attract renewed investor interest.
- Market Sentiment Analysis: Wood's decision to increase her holdings during market downturns reflects her confidence in long-term growth, and despite facing stock price volatility and market concerns in the short term, her investment strategy may yield substantial returns in the future.
See More
Ark Invest Increases Stakes in Multiple AI Firms
- Tempus AI Acquisition: Ark Invest significantly increased its position in Tempus AI by purchasing 1,192 shares through the ARK Genomic Revolution ETF and an additional 6,545 shares via the ARK Innovation ETF, totaling approximately $523,253, indicating strong confidence in the company's future.
- Kodiak AI Purchase: The firm acquired 47,752 shares of Kodiak AI through the ARK Autonomous Technology & Robotics ETF, with a total transaction value of $427,380 despite a 4.58% decline in stock price, reflecting ongoing optimism in autonomous driving technology.
- WeRide Investment: Ark Invest also purchased 48,260 shares of WeRide through ARKQ, amounting to approximately $417,449, highlighting its focus on the Chinese robotaxi market, especially as the fleet surpasses 1,000 vehicles.
- Other Trading Activities: Ark sold 64,695 shares of Twist Bioscience and 67,086 shares of 10X Genomics, showcasing its flexible adjustment strategy within its investment portfolio.
See More
Cathie Wood's ETFs Outperform Market in 2026; Netflix Loses $82 Billion in Market Cap
- Netflix Market Cap Loss: Netflix's stock has plummeted 35% since its summer peak, resulting in an $82 billion market cap loss, reflecting the market pressure following its acquisition of Warner Bros. Discovery, which has weakened investor confidence in future growth.
- Earnings Report Performance: Despite Netflix's Q4 revenue rising 18% year-over-year and net income increasing by 30%, the 2026 operating margin outlook of only 31.5% fell short of market expectations, prompting analysts to lower earnings targets for the next two years.
- Tempus AI Growth Momentum: Tempus AI has seen revenue growth of 75%, 90%, and 85% in the first three quarters of 2025, indicating strong demand for its oncology and hereditary testing products, although growth is expected to decelerate to 24% in 2026.
- Kodiak AI Market Potential: Kodiak AI, with a market cap of only $1.6 billion, focuses on the commercial trucking and public sector markets, having driven over 3 million miles in just four months, showcasing its unique business model and potential for future growth.
See More
ARK Invest Deepens AI Chip and Gene Editing Investments, Sells 86K Tesla Shares
- AI Infrastructure Boost: ARK Invest increased positions in semiconductor companies like AMD, Broadcom, and TSMC, signaling strong confidence in the infrastructure for AI workloads, which is expected to drive long-term growth for these firms.
- Gene Editing Investments: The firm added 196K shares of Intellia Therapeutics and 49K shares of 10x Genomics, continuing to focus on next-generation sequencing and in vivo gene editing, aiming to capture innovative opportunities in the biotech sector.
- Autonomous Driving Focus: ARK invested in companies like WeRide and Pony AI in the autonomous driving and robotics space, reinforcing its strategic positioning in future transportation technologies, which is likely to enhance portfolio diversity and potential returns.
- Trimmed Mature Tech Holdings: ARK sold over 86K shares of Tesla worth more than $37 million and reduced stakes in Unity Software, reflecting a cautious stance on mature tech companies that may impact short-term stock performance.
See More
Cathie Wood Increases Stakes in Broadcom, Klarna, and Kodiak AI
- Broadcom's Strong Performance: Broadcom reported a 28% year-over-year revenue increase in its last quarter, driven by a 74% surge in AI semiconductor revenue, with analysts projecting a 51% revenue growth for the upcoming fiscal year, highlighting its critical position in global internet traffic and attracting Wood's investment.
- Klarna's Post-IPO Dip: Klarna's stock has fallen 22% since its IPO four months ago, despite a 28% revenue growth in its first quarter, with stronger performance in the U.S. and European markets, indicating Wood's interest in its future growth potential.
- Kodiak AI's Technological Promise: Kodiak AI focuses on autonomous driving technology for commercial trucking, currently operating 10 customer-owned trucks, but has logged over 3 million miles on its platform, showcasing significant market application potential that has caught analysts' attention.
- Investment Strategy Insight: Wood's decision to increase stakes in these stocks amid market fluctuations reflects her confidence in tech stocks, particularly in the AI and fintech sectors, which could yield substantial returns for Ark Invest.
See More
ARK Invest Sells $12.7M in Meta Shares, Acquires $12.8M in Roblox Shares
- Meta Share Divestment: On Tuesday, ARK Invest sold 19,316 shares of Meta for approximately $12.7 million, reflecting a strategic shift amid delays in the global launch of Ray-Ban smart glasses, indicating a prioritization of domestic demand.
- Roblox Share Acquisition: The same day, ARK Invest acquired 169,130 shares of Roblox valued at about $12.8 million through its ETFs, demonstrating confidence in the company's gaming market potential, despite analysts lowering future price targets.
- Investment in Kodiak AI: ARK purchased 39,296 shares of Kodiak AI for approximately $381,171, highlighting ongoing interest in the driverless truck sector, although the company's market performance remains to be seen.
- Other Trading Activities: ARK also sold 17,613 shares of Guardant Health and 7,228 shares of Ionis Pharmaceuticals, showcasing flexibility and strategic adjustments within its diversified investment portfolio.
See More
Cathie Wood's Investment Outlook for 2026
- Joby Aviation Investment: Despite Joby Aviation's stock plummeting 17% after announcing a $1.2 billion stock and convertible note offering, it still achieved a 33% return over the past year, indicating market confidence in the long-term potential of electric vertical takeoff and landing aircraft, with Wood's increased stake signaling her bullish outlook.
- Kodiak AI Challenges: Kodiak AI's market cap has dropped from $2.5 billion to $1.6 billion, and while its technology in autonomous trucking is promising, the current operation of only 10 commercial vehicles suggests insufficient market acceptance, making Wood's investment a bet on future growth potential.
- CRISPR Therapeutics Outlook: CRISPR set multiple milestones for 2026, with its Casgevy treatment generating over $100 million in revenue last year; despite its stock being down 76% from its all-time high five years ago, plans to expand treatment usage may attract renewed investor interest.
- Market Sentiment Analysis: Wood's decision to increase her holdings during market downturns reflects her confidence in long-term growth, and despite facing stock price volatility and market concerns in the short term, her investment strategy may yield substantial returns in the future.
See More
Ark Invest Increases Stakes in Multiple AI Firms
- Tempus AI Acquisition: Ark Invest significantly increased its position in Tempus AI by purchasing 1,192 shares through the ARK Genomic Revolution ETF and an additional 6,545 shares via the ARK Innovation ETF, totaling approximately $523,253, indicating strong confidence in the company's future.
- Kodiak AI Purchase: The firm acquired 47,752 shares of Kodiak AI through the ARK Autonomous Technology & Robotics ETF, with a total transaction value of $427,380 despite a 4.58% decline in stock price, reflecting ongoing optimism in autonomous driving technology.
- WeRide Investment: Ark Invest also purchased 48,260 shares of WeRide through ARKQ, amounting to approximately $417,449, highlighting its focus on the Chinese robotaxi market, especially as the fleet surpasses 1,000 vehicles.
- Other Trading Activities: Ark sold 64,695 shares of Twist Bioscience and 67,086 shares of 10X Genomics, showcasing its flexible adjustment strategy within its investment portfolio.
See More
Cathie Wood's ETFs Outperform Market in 2026; Netflix Loses $82 Billion in Market Cap
- Netflix Market Cap Loss: Netflix's stock has plummeted 35% since its summer peak, resulting in an $82 billion market cap loss, reflecting the market pressure following its acquisition of Warner Bros. Discovery, which has weakened investor confidence in future growth.
- Earnings Report Performance: Despite Netflix's Q4 revenue rising 18% year-over-year and net income increasing by 30%, the 2026 operating margin outlook of only 31.5% fell short of market expectations, prompting analysts to lower earnings targets for the next two years.
- Tempus AI Growth Momentum: Tempus AI has seen revenue growth of 75%, 90%, and 85% in the first three quarters of 2025, indicating strong demand for its oncology and hereditary testing products, although growth is expected to decelerate to 24% in 2026.
- Kodiak AI Market Potential: Kodiak AI, with a market cap of only $1.6 billion, focuses on the commercial trucking and public sector markets, having driven over 3 million miles in just four months, showcasing its unique business model and potential for future growth.
See More
ARK Invest Deepens AI Chip and Gene Editing Investments, Sells 86K Tesla Shares
- AI Infrastructure Boost: ARK Invest increased positions in semiconductor companies like AMD, Broadcom, and TSMC, signaling strong confidence in the infrastructure for AI workloads, which is expected to drive long-term growth for these firms.
- Gene Editing Investments: The firm added 196K shares of Intellia Therapeutics and 49K shares of 10x Genomics, continuing to focus on next-generation sequencing and in vivo gene editing, aiming to capture innovative opportunities in the biotech sector.
- Autonomous Driving Focus: ARK invested in companies like WeRide and Pony AI in the autonomous driving and robotics space, reinforcing its strategic positioning in future transportation technologies, which is likely to enhance portfolio diversity and potential returns.
- Trimmed Mature Tech Holdings: ARK sold over 86K shares of Tesla worth more than $37 million and reduced stakes in Unity Software, reflecting a cautious stance on mature tech companies that may impact short-term stock performance.
See More
Cathie Wood Increases Stakes in Broadcom, Klarna, and Kodiak AI
- Broadcom's Strong Performance: Broadcom reported a 28% year-over-year revenue increase in its last quarter, driven by a 74% surge in AI semiconductor revenue, with analysts projecting a 51% revenue growth for the upcoming fiscal year, highlighting its critical position in global internet traffic and attracting Wood's investment.
- Klarna's Post-IPO Dip: Klarna's stock has fallen 22% since its IPO four months ago, despite a 28% revenue growth in its first quarter, with stronger performance in the U.S. and European markets, indicating Wood's interest in its future growth potential.
- Kodiak AI's Technological Promise: Kodiak AI focuses on autonomous driving technology for commercial trucking, currently operating 10 customer-owned trucks, but has logged over 3 million miles on its platform, showcasing significant market application potential that has caught analysts' attention.
- Investment Strategy Insight: Wood's decision to increase stakes in these stocks amid market fluctuations reflects her confidence in tech stocks, particularly in the AI and fintech sectors, which could yield substantial returns for Ark Invest.
See More
ARK Invest Sells $12.7M in Meta Shares, Acquires $12.8M in Roblox Shares
- Meta Share Divestment: On Tuesday, ARK Invest sold 19,316 shares of Meta for approximately $12.7 million, reflecting a strategic shift amid delays in the global launch of Ray-Ban smart glasses, indicating a prioritization of domestic demand.
- Roblox Share Acquisition: The same day, ARK Invest acquired 169,130 shares of Roblox valued at about $12.8 million through its ETFs, demonstrating confidence in the company's gaming market potential, despite analysts lowering future price targets.
- Investment in Kodiak AI: ARK purchased 39,296 shares of Kodiak AI for approximately $381,171, highlighting ongoing interest in the driverless truck sector, although the company's market performance remains to be seen.
- Other Trading Activities: ARK also sold 17,613 shares of Guardant Health and 7,228 shares of Ionis Pharmaceuticals, showcasing flexibility and strategic adjustments within its diversified investment portfolio.
See More
